Valganciclovir Therapy in Infants and Children With Congenital CMV Infection and Hearing Loss

NCT01649869 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

54

Enrollment

NIH

Sponsor class

Conditions

Cytomegalovirus Infection

Interventions

OTHER: Placebo
DRUG: Valganciclovir

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)